Synopsis:
Shares surged over 5% following robust Q1 results, with revenue and net profit rising 17% and 53% YoY, respectively. Strong EBITDA growth, margin expansion, ongoing capacity additions, and a broad range of specialties highlight continued operational strength and growth momentum.
The shares of the prominent healthcare services gained up to 5.4 percent in today’s trading session after the company’s net profit and revenue surged 53 percent and 17 percent, respectively, in Q1FY25.
With a market capitalization of Rs 67,493.26 crore, the shares of Fortis Healthcare Ltd were trading at Rs 904.00 per share, increasing around 5.40 percent as compared to the previous closing price of Rs 857.70 apiece.
Q1FY26 Highlights
The shares of Fortis Healthcare Ltd have seen positive movement after reporting positive results in Q1FY26. Revenue increased by 8 percent on a quarter-on-quarter basis from Rs. 2,007 crore in Q4FY25 to Rs. 2,167 crore in Q1FY26. Further, revenue increased by 17 percent year on year, from Rs 1,859 crore in Q1FY25 to Rs 2,167 crore in Q1FY26.
The company’s net profit increased by 42 percent on a quarter-on-quarter basis, from Rs.188 crore in Q4FY25 to Rs. 267 crore in Q1FY26. Further, net profit increased significantly by 53 percent year on year from Rs 174 crore in Q1FY25 to Rs 267 crore in Q1FY26.
The company delivered strong operational performance in Q1, with EBITDA rising 43% YoY to ₹491 crore from ₹343 crore. This growth reflects improved efficiency and cost management. EBITDA margin also expanded significantly to 22.6% from 18.4% in the same period last year, indicating healthier profitability and a solid start to the fiscal year.
Fortis Healthcare operates 33 facilities across India with over 5,700 operational beds and a workforce of 24,000+, including 6,800+ doctors and 8,000+ nurses. The National Capital Region holds the highest bed count at 1,978, followed by Punjab and Karnataka. Accredited by JCI and NABH, Fortis stands among the most accredited healthcare networks in India, emphasizing quality care nationwide.
Fortis Healthcare posted strong Q1FY26 results, with hospital revenues rising 18.6% YoY to ₹1,838 Cr. EBITDA surged 41.4% to ₹406 Cr, and margins improved to 22.1%. ARPOB rose 10.2% to ₹2.65 Cr. Occupancy reached 69%. The diagnostics segment grew 7.4% to ₹368.8 Cr, with EBITDA margin improving to 23% from 16.1% YoY, reflecting operational efficiency.
Fortis Healthcare is actively expanding, adding ~300 beds at Manesar, with 96 already operational and the remainder scheduled for completion by Q3 FY26. In Noida, 60 out of 150 beds are live, with the remainder expected in Q3FY26. New towers in Faridabad (50 beds) and FMRI (200 beds) will be operational in FY26, boosting capacity and enhancing regional healthcare access.
Fortis Healthcare Limited is primarily engaged in the healthcare services business. The Company operates through the healthcare services segment. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, pulmonology, urology, neurosurgery, radiology, orthopedics, and organ transplant, among others.
Written by Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Midcap stock jumps 5% after company’s net profit increases 53% YoY appeared first on Trade Brains.